tradingkey.logo
tradingkey.logo
検索

TELA Bio Inc

TELA
ウォッチリストに追加
0.970USD
+0.065+7.18%
終値 09-11 16:00ET
42.59M時価総額
損失額直近12ヶ月PER

詳細情報 TELA Bio Inc 企業名

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

TELA Bio Inc プロフィール

企業コードTELA
会社名TELA Bio Inc
上場日Nov 08, 2019
最高経営責任者「CEO」Koblish (Antony)
従業員数209
証券種類Ordinary Share
決算期末Nov 08
本社所在地1 Great Valley Parkway, Suite 24
都市MALVERN
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号19355
電話番号14843202930
ウェブサイトhttps://www.telabio.com/
企業コードTELA
上場日Nov 08, 2019
最高経営責任者「CEO」Koblish (Antony)

TELA Bio Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Chief Executive Officer, Principal Executive Officer and Principal Financial Officer, Director
Chief Executive Officer, Principal Executive Officer and Principal Financial Officer, Director
532.50K
--
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
396.29K
-23.08%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
52.35K
-279.66%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
23.60K
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Director
Independent Director
23.60K
--
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
18.47K
+23.01%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
18.47K
+23.01%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
18.47K
+23.01%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
11.68K
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Chief Executive Officer, Principal Executive Officer and Principal Financial Officer, Director
Chief Executive Officer, Principal Executive Officer and Principal Financial Officer, Director
532.50K
--
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
396.29K
-23.08%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
52.35K
-279.66%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
23.60K
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Director
Independent Director
23.60K
--

よくある質問

TELA Bio Incの上位5名の株主は誰ですか?

TELA Bio Incの上位5名の株主は以下のとおりです。Ms. Heather C. Getz, CPA

TELA Bio Inc(TELA)の株式を保有している機関の数はいくつですか?

2026Q1時点で、TELA Bio Incの株式を保有している機関は163社あり、保有株式の総市場価値は約32.85Mで、全体の73.39%を占めています。2025Q4と比較して、機関の持ち株は-6147477.00増加しています。

TELA Bio Incの最大の収益源は何ですか?

2026Q1において、OviTex部門がTELA Bio Incにとって最大の収益を生み出しており、その金額は13.31Mで、全収益の68.99%を占めています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。